All In MedTech

FDA Clearance Tracker · P150035-S021

Aveir™ VR Leadless Pacemaker, Aveir™ DR Leadless Pacemaker

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 16, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 16, 2025

Approved

Time to decision

30 days

Received Dec 17, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150035-S021
Device name
Aveir™ VR Leadless Pacemaker, Aveir™ DR Leadless Pacemaker
Applicant location
Sylmar, CA
Received
Dec 17, 2024
Decided
Jan 16, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150035

Device type

Device class
Class III
Regulation
21 CFR 870.3610

Every decision under product code PNJ

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site located at Abbott Medical, Lot A Interior - # 2 Rd. Km. 67.5, Santana Industrial Park, Arecibo, Puerto Rico 00612 USA for sterilization, final packaging and labeling activities, and final acceptance and distribution of the device

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.